Sections
Business | Pulse | Labour & Employment | Wills, Trusts & Estates | Family | Criminal | Civil Litigation | Personal Injury | Access to Justice
In-House Counsel | Insurance | Intellectual Property | Immigration | Natural Resources | Real Estate | Tax

Competition Bureau completes preliminary investigation concerning relabelled biologic drugs

By Daniel Escudero ( June 27, 2022, 4:53 PM EDT) -- The Competition Bureau has completed a preliminary investigation into potential anticompetitive harm from relabelled biologic drugs, and has closed that investigation because the drugs in question have not been marketed in Canada....

Related Sections